Overview
Chetan Belaldavar practices practicing medicine in Belgaum, India.
His clinical expertise encompasses Oral Submucous Fibrosis, Rosai-Dorfman Disease, and Lichen Planus.
He is actively involved in clinical research, co-authoring 9 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Chetan Belaldavar
Is Chetan Belaldavar a top-rated expert for Oral Submucous Fibrosis?
MediFind is an objective health platform that identifies experts based on real-world data. Chetan Belaldavar is classified as an Experienced expert for Oral Submucous Fibrosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Chetan Belaldavar participate in research or clinical trials?
Yes. Chetan Belaldavar has published 9 articles and abstracts on conditions like Oral Submucous Fibrosis. You can view a list of Chetan Belaldavar's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Lichen PlanusMr. Belaldavar isExperienced. Learn about Lichen Planus.
- Oral Submucous FibrosisMr. Belaldavar isExperienced. Learn about Oral Submucous Fibrosis.
- Rosai-Dorfman DiseaseMr. Belaldavar isExperienced. Learn about Rosai-Dorfman Disease.